Literature DB >> 11787050

IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry.

Han You1, Hongwu Zheng, Steven A Murray, Qiang Yu, Takafumi Uchida, Daiming Fan, Zhi-Xiong Jim Xiao.   

Abstract

Insulin-like growth factor I (IGF-1) is a well-established mitogen to many different cell types and is implicated in progression of a number of human cancers, notably breast cancer. The prolyl isomerase Pin1 plays an important role in cell cycle regulation through its specific interaction with proteins that are phosphorylated at Ser/Thr-Pro motifs. Pin1 knockout mice appear to have relatively normal development yet the Pin1(-/-)mouse embryo fibroblast (MEF) cells are defective in re-entering cell cycle in response to serum stimulation after G0 arrest. Here, we report that Pin1(-/-) MEF cells display a delayed cell cycle S-phase entry in response to IGF stimulation and that IGF-1 induces Pin1 protein expression which correlates with the induction of cyclin D1 and RB phosphorylation in human breast cancer cells. The induction of Pin1 by IGF-1 is mediated via the phosphatidylinositol 3-kinase as well as the MAP kinase pathways. Treatment of PI3K inhibitor LY294002 and the MAP kinase inhibitor PD098059, but not p38 inhibitor SB203580, effectively blocks IGF-1-induced upregulation of Pin1, cyclin D1 and RB phosphorylation. Furthermore, we found that Cyclin D1 expression and RB phosphorylation are dramatically decreased in Pin1(-/-) MEF cells. Reintroducing a recombinant adenovirus encoding Pin1 into Pin1(-/-) MEF cells restores the expression of cyclin D1 and RB phosphorylation. Thus, these data suggest that the mitogenic function of IGF-1 is at least partially linked to the induction of Pin1, which in turn stimulates cyclin D1 expression and RB phosphorylation, therefore contributing to G0/G1-S transition. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11787050     DOI: 10.1002/jcb.10037

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

1.  B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells.

Authors:  Frank Secreto; Michelle Manske; Tammy Price-Troska; Steven Ziesmer; Lucy S Hodge; Stephen M Ansell; James R Cerhan; Anne J Novak
Journal:  Leuk Lymphoma       Date:  2014-02-24

2.  PML: An emerging tumor suppressor and a target with therapeutic potential.

Authors:  Erin L Reineke; Hung-Ying Kao
Journal:  Cancer Ther       Date:  2009-09-01

Review 3.  Landscape of Pin1 in the cell cycle.

Authors:  Cheng-Han Lin; Hao-Yi Li; Yu-Cheng Lee; Marcus J Calkins; Kuen-Haur Lee; Chia-Ning Yang; Pei-Jung Lu
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

4.  Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation.

Authors:  Sung Hwan Ki; Jung-Woon Lee; Sung Chul Lim; Tran Thi Hien; Ji Hye Im; Won Keun Oh; Moo Yeol Lee; Young Hyun Ji; Yoon Gyoon Kim; Keon Wook Kang
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.

Authors:  Kwang Youl Lee; Jeong Woon Lee; Hyun Jeong Nam; Jeong-Hyun Shim; Youngsup Song; Keon Wook Kang
Journal:  Mol Cells       Date:  2011-05-11       Impact factor: 5.034

6.  Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma.

Authors:  Brian L Teng; Kathryn E Hacker; Shufen Chen; Anthony R Means; W Kimryn Rathmell
Journal:  Mol Oncol       Date:  2011-06-28       Impact factor: 6.603

Review 7.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.

Authors:  Yih-Cherng Liou; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2011-08-17       Impact factor: 13.807

8.  Synthetic lethality of retinoblastoma mutant cells in the Drosophila eye by mutation of a novel peptidyl prolyl isomerase gene.

Authors:  Kyle A Edgar; Marcia Belvin; Annette L Parks; Kellie Whittaker; Matt B Mahoney; Monique Nicoll; Christopher C Park; Christopher G Winter; Feng Chen; Kim Lickteig; Ferhad Ahmad; Hanife Esengil; Matthew V Lorenzi; Amanda Norton; Brent A Rupnow; Laleh Shayesteh; Mariano Tabios; Lynn M Young; Pamela M Carroll; Casey Kopczynski; Gregory D Plowman; Lori S Friedman; Helen L Francis-Lang
Journal:  Genetics       Date:  2005-03-02       Impact factor: 4.562

9.  Regulation of cardiac hypertrophic signaling by prolyl isomerase Pin1.

Authors:  Haruhiro Toko; Mathias H Konstandin; Shirin Doroudgar; Lucia Ormachea; Eri Joyo; Anya Y Joyo; Shabana Din; Natalie A Gude; Brett Collins; Mirko Völkers; Donna J Thuerauf; Christopher C Glembotski; Chun-Hau Chen; Kun Ping Lu; Oliver J Müller; Takafumi Uchida; Mark A Sussman
Journal:  Circ Res       Date:  2013-03-13       Impact factor: 17.367

10.  Pin1: a therapeutic target in Alzheimer neurodegeneration.

Authors:  Malika Hamdane; Caroline Smet; Anne-Véronique Sambo; Arnaud Leroy; Jean-Michel Wieruszeski; Patrice Delobel; Claude-Alain Maurage; Antoine Ghestem; René Wintjens; Séverine Bégard; Nicolas Sergeant; André Delacourte; Dragos Horvath; Isabelle Landrieu; Guy Lippens; Luc Buée
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.